Woburn, MA – Ametros Financial Corporation, a cost containment and compliance company in the insurance services sector that provides professional administration of Medicare Set-Asides (MSAs) and other medical custodial accounts through its patented CareGuard product, and Work Loss Data Institute (WLDI), the publisher of the industry leading Official Disability Guidelines (ODG), have entered into an exclusive strategic partnership to develop and provide technology-enabled cost containment services.
Ametros’ patented point-of-sale technology and medical management processes combined with WLDI’s medical treatment expertise and unique databases will produce an unrivaled service to manage post-settlement MSAs and custodial accounts, as well as provide innovative, technology driven pre-settlement cost containment solutions to the country’s leading insurance carriers, third party administrators, and self-insured organizations.
“We are truly excited about the opportunity to partner with the industry’s leading medical guidelines company and evidence-based medicine thought leaders to develop innovative medical management products and services for our joint clients,” said Marques Torbert, Chief Executive Officer of Ametros. “Not only will this strategic partnership enhance our ability to professionally administer MSAs, it will also create opportunities to leverage both organization’s expertise, technology, and data for future advancements.”
This is a natural partnership for both companies. WLDI provides evidence-based decision support for managing medical treatment and utilization review in workers’ compensation, general health, and disability cases. WLDI’s evidence based guidelines and return to work tools have been widely adopted, including 32 states and provinces in North America that have adopted ODG in one form or another, with another 10 considering ODG adoption. Furthermore, ODG is broadly recognized in all states by providers and payors. Additionally, Ametros has garnered expertise in utilizing proprietary and novel managed care techniques and systems to facilitate and manage medical care transactions.
The strategic partnership results in WLDI taking an equity ownership stake in Ametros, as well as Ametros electing Phil Denniston, President of WLDI, to the Board of Directors of Ametros. “Our mission is to apply evidence-based medicine to improve healthcare outcomes. With their patented technology and proven expertise, Ametros is in a unique position to help us further this mission, to the ultimate benefit of employers and their employees,” commented Mr. Denniston.
“We are very excited to welcome Phil and the rest of the WLDI team to the Ametros family,” remarked Ametros’ CEO. “Ametros continually transforms the MSA industry and we are looking forward to accelerating our pace of innovation within the broader insurance services market with our new partner.”
Source: WLDI